The study will test whether people on weekly semaglutide or tirzepatide for weight can switch to a monthly treatment. Recruitment opens soon.
Recap by typeshit. Post by Facebook on Facebook.
A Facebook share says Danish teams found certain bacterial strains may change how the gut tells the brain it is full. The work so far is in animal models only.
Bikman calls the results remarkable, but he argues that bigger drops make it more important to know how much of the lost weight is fat and how much is muscle.
Bikman points out that weight usually returns once the drug is stopped, which makes the question of lifelong use a real one.
Avi Roy flags a preprint that pooled 10,052 people from five semaglutide trials and used a blood test to estimate heart age. It has not yet been peer reviewed.
Men's Health shares a guide on holding onto muscle mass when GLP-1 drugs cut your appetite and calorie intake.
A first-person take from Wine Enthusiast on how starting Ozempic shifted the experience of tasting and enjoying wine.
Loading…